Baseline clinical data
| Mean (SD) | |
|---|---|
| ACEI, angiotensin converting enzyme inhibitor; AF, atrial fibrillation; ARB, angiotensin receptor blocker; DBP, diastolic blood pressure; DCM, dilated cardiomyopathy; HF, heart failure; IHD, ischaemic heart disease; LVH, left ventricular hypertrophy; NIDDM, non-insulin dependent diabetes mellitus; NYHA, New York Heart Association; SBP, systolic blood pressure. | |
| Age (years) | 67.5 (7.05) |
| Male/female | 35/8 |
| NYHA class I/II | 15/28 |
| HF aetiology HT/IHD/DCM | 9/29/5 |
| IHD | 38 (88%) |
| LVH | 9 (21%) |
| NIDDM | 4 (9%) |
| AF | 1 (2%) |
| SBP (mm Hg) | 137 (21.0) |
| DBP (mm Hg) | 76.8 (9.79) |
| Sodium (mmol/l) | 139 (2.78) |
| Potassium (mmol/l) | 4.37 (0.34) |
| Urea (mmol/l) | 7.29 (2.50) |
| Creatinine (μmol/l) | 111 (27.2) |
| Furosemide (mg) | 33.0 (38.0) |
| Aspirin | 38 (88%) |
| Warfarin | 3 (12%) |
| ACE inhibitor/ARB | 36 (84%)/7 (16%) |
| Statin | 25 (58%) |
| β Blocker | 31 (72%) |
| Digoxin | 4 (9%) |